MedTrace Logo

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

NCT06213818 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2025-10-14

No results posted yet for this study

Summary

This study is being conducted to assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participants.

Conditions

  • Healthy Participants

Interventions

DRUG

INCB160058

Oral; Immediate release solid tablet

DRUG

Placebo

Oral; Tablet

DRUG

Esomeprazole

Oral; Delayed-release capsule or tablet

DRUG

Famotidine

Oral; Tablet

Sponsors & Collaborators

Principal Investigators

  • Incyte Medical · Incyte Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-14
Primary Completion
2025-08-19
Completion
2025-08-19

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213818 on ClinicalTrials.gov